| 1 |
A Multicenter, Randomized, Open, Comparative Study for the Efficacy and Safety of Oral Moxifloxacin 400 mg Once a Day and Clarithromycin 500 mg Twice Daily in Korean Patients with Acute Exacerbations of Chronic Bronchitis
Seung Joon Kim, Seok Chan Kim, Sook Young Lee, Hyeong Kyu Yoon, Tae Yon Kim, Young Kyoon Kim, Jeong Sup Song, Sung Hak Park, Ho Joong Kim, Man Pyo Chung, Gee Young Suh, O Jung Kwon, Shin Hyung Lee, Kyung Ho Kang, Eh Hyung Lee, Sung Chul Hwang, Myung Ho Ha
|
| 2 |
A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Oral LB20304 (Gemifloxacin) at Doses of 160mg or 320mg (Equivalent to 200mg or 400mg of the Mesylate Salt) Once Daily for 7 Days for the Treatment of Acute Exacerbations of Chronic Bronchitis (AECB) in Korean Adult Population
Young Whan Kim, Young-Soo Shim, Won Dong Kim, Tae Sun Shim, Hong Mo Kang, ByoungWhui Choi, Jae-Yeol Kim, O Jung Kwon, Hojoong Kim, Ju Ock Kim, Ki-Suck Jung, In Gyou Hyeon, Eun Kyung Mo, Seung-Joon Lee, Gui Hyun Nam, Kye Young Lee, Jae Seuk Park
|
